Penumbra Inc (PEN)
205.62
+2.62
(+1.29%)
USD |
NYSE |
Apr 23, 16:00
205.62
0.00 (0.00%)
After-Hours: 20:00
Penumbra Enterprise Value: 7.568B for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 7.568B |
| April 19, 2024 | 7.557B |
| April 18, 2024 | 7.523B |
| April 17, 2024 | 7.788B |
| April 16, 2024 | 7.841B |
| April 15, 2024 | 7.846B |
| April 12, 2024 | 8.127B |
| April 11, 2024 | 8.321B |
| April 10, 2024 | 8.268B |
| April 09, 2024 | 8.338B |
| April 08, 2024 | 8.228B |
| April 05, 2024 | 8.379B |
| April 04, 2024 | 8.050B |
| April 03, 2024 | 8.032B |
| April 02, 2024 | 7.897B |
| April 01, 2024 | 8.125B |
| March 28, 2024 | 8.349B |
| March 27, 2024 | 8.473B |
| March 26, 2024 | 8.259B |
| March 25, 2024 | 8.229B |
| March 22, 2024 | 8.409B |
| March 21, 2024 | 8.518B |
| March 20, 2024 | 8.860B |
| March 19, 2024 | 8.959B |
| March 18, 2024 | 8.781B |
| Date | Value |
|---|---|
| March 15, 2024 | 8.309B |
| March 14, 2024 | 8.595B |
| March 13, 2024 | 8.745B |
| March 12, 2024 | 8.971B |
| March 11, 2024 | 9.062B |
| March 08, 2024 | 9.175B |
| March 07, 2024 | 9.499B |
| March 06, 2024 | 9.365B |
| March 05, 2024 | 9.638B |
| March 04, 2024 | 9.368B |
| March 01, 2024 | 8.871B |
| February 29, 2024 | 8.803B |
| February 28, 2024 | 8.641B |
| February 27, 2024 | 8.702B |
| February 26, 2024 | 8.661B |
| February 23, 2024 | 8.937B |
| February 22, 2024 | 9.878B |
| February 21, 2024 | 9.708B |
| February 20, 2024 | 10.11B |
| February 16, 2024 | 10.18B |
| February 15, 2024 | 10.28B |
| February 14, 2024 | 10.10B |
| February 13, 2024 | 9.958B |
| February 12, 2024 | 10.16B |
| February 09, 2024 | 10.28B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.134B
Minimum
Jun 16 2022
12.99B
Maximum
Jun 30 2023
7.842B
Average
8.040B
Median
Enterprise Value Benchmarks
| Stryker Corp | 134.55B |
| Boston Scientific Corp | 108.27B |
| Insulet Corp | 12.21B |
| Shockwave Medical Inc | 12.03B |
| Stereotaxis Inc | 191.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.22M |
| Revenue (Quarterly) | 284.68M |
| Total Expenses (Quarterly) | 249.65M |
| EPS Diluted (Quarterly) | 1.38 |
| Gross Profit Margin (Quarterly) | 65.69% |
| Profit Margin (Quarterly) | 19.05% |
| Earnings Yield | 1.12% |
| Operating Earnings Yield | 1.14% |
| Normalized Earnings Yield | 1.280 |